CEACAM5 and neoplasm: Third, although we included key clinical variables such as PD-L1 expression, distant metastasis, and CEA, additional immune-metabolic interactions (e.g., immune cell subsets in the tumor microenvironment, metabolic enzymes) were not considered in the model.